- Coordinator
- Lunds Universitet, Sweden
- Runs
- 1 August 2022 to 31 July 2024
- Status
- Finished
- EU funding
- €223k
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101067501
What the project is doing
In the project's own words, from its summary on CORDIS.
Cellular reprogramming has revolutionized stem cell biology by allowing the generation of stem cells, progenitors, or somatic cell identities with small combinations of transcription factors (TFs). Currently, the limited understanding of how these different degrees of plasticity are established and maintained keeps on hold the application of reprogrammed cells in the clinic. With the RePLASTIC project, I propose to uncover novel regulators that define degrees of plasticity and control cell identity, with an interdisciplinary approach merging the fields of gene editing, stem cells and immunology.
I will develop an innovative platform to evaluate the impact of gene knockout across the process of cell reprogramming in human cells, comparing multiple cell conversion scenarios: pluripotency, multipotency (hematopoietic stem cells) and unipotency (dendritic cells). For this, I will carry out a CRISPR/Cas9 knockout screening coupled with next-generation sequencing using custom-designed sgRNA libraries targeting TFs, chromatin regulators, and RNA modifiers.
After sequencing, I will determine the molecular targets that are relevant by comparing the three reprogramming systems. Genes involved in cell conversion will be defined as regulators of plasticity, and top hits will be validated to study their molecular mechanism and role. Certainly, RePLASTIC will open new research avenues on the basic principles of cellular plasticity and provide ground-breaking technologies that may contribute to immunotherapy, regeneration and cancer.
I will pursue this project as an incoming researcher supervised by Dr. Filipe Pereira (Lund University, Sweden). During my stay, I will acquire hands-on expertise in cutting-edge techniques: direct reprogramming, hematopoietic/immune cells, gene editing, deep sequencing. I will also gain experience in mentorship and writing skills and expand my network by attending national and international meetings to present my work and foster new collaborations.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Lunds Universitet | Lund | Sweden | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI